This is a Phase 2B, randomized, assessor-blind, active- and saline placebo-controlled,
multicenter study in subjects undergoing augmentation mammoplasty to evaluate the analgesic
efficacy, safety, and pharmacokinetics (PK) of HTX-011 when administered via
ultrasound-guided lateral and medial pectoral nerve block before surgery.